Presentation and outcomes of chronic kidney disease patients with COVID-19.

Autor:	Branco CG; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Duarte I; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Gameiro J; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Costa C; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Marques F; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Oliveira J; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Bernardo J; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Fonseca JN; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal., Carreiro C; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Medicina Interna 2, Lisboa, Portugal., Braz S; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Medicina Interna 2, Lisboa, Portugal., Lopes JA; Centro Hospitalar Universitário Lisboa Norte, Departamento de Medicina, Divisão de Nefrologia e Transplante Renal, Lisboa, Portugal.
Jazyk:	English; Portuguese
Zdroj:	Jornal brasileiro de nefrologia [J Bras Nefrol] 2022 Jul-Sep; Vol. 44 (3), pp. 321-328.
DOI:	10.1590/2175-8239-JBN-2021-0071
Abstrakt:	Introduction: COVID-19 is currently a global health issue and an important cause of mortality. Chronic kidney disease (CKD) is one of the risk factors for infection, morbidity and mortality by SARS-CoV-2. In our study, we aimed to evaluate the clinical presentation and outcomes of CKD patients with COVID-19, as well as identify predictors of mortality. Methods: This was a retrospective study of CKD patients admitted in a tertiary-care Portuguese hospital between March and August of 2020. Variables were submitted to univariate and multivariate analysis to determine factors predictive of in-hospital mortality. Results: 130 CKD patients were analyzed (median age 73.9 years, male 60.0%). Hypertension (81.5%), cardiovascular disease (36.2%), and diabetes (54.6%) were frequent conditions. Cough, dyspnea, fever and respiratory failure were also common. Almost 60% had anemia, 50% hypoalbuminemia, 13.8% hyperlactacidemia and 17% acidemia. Mean serum ferritin was 1531 µg/L, mean CRP 8.3 mg/dL and mean LDH 336.9 U/L. Most patients were treated with lopinavir/ritonavir, hydroxychloroquine or corticosteroids and only 2 with remdesivir. Eighty percent had acute kidney injury and 16.2% required intensive care unit admission. The 34 patients who died were older and more likely to have heart failure. They had higher neutrophils/lymphocytes ratio, ferritin, lactate, and LDH levels. Multivariate analysis identified an association between older age [OR 1.1 (CI 1.01-1.24), p=0.027], higher ferritin [OR 1.0 (CI 1.00-1.00), p=0.009] and higher LDH levels [OR 1.0 (CI 1.00-1.01), p=0.014] and mortality. Conclusion: In our cohort of CKD patients with COVID-19, older age, higher ferritin, and higher LDH levels were independent risk factors for mortality.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu